Management of secondary risk factors in patients with intermittent claudication
Authors:
- R. CoullRCR. Coull
- P. BachooPBP. Bachoo
- E. MacaulayEME. Macaulay
- J. BrittendenJBJ. Brittenden
- 1 September 2003
- journal article
- research article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 26 (3) , 262-266
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Prevalence and treatment of hypercholesterolaemia in patients with peripheral vascular diseaseBritish Journal of Surgery, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Incidence, Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General PopulationInternational Journal of Epidemiology, 1996
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- National Study of Obliterative Arterial Disease of the Lower Limbs Involving General Practitioners in FranceJournal of Cardiovascular Pharmacology, 1995
- Treating claudication in five wordsBMJ, 1988
- Fate in intermittent claudication: outcome and risk factors.BMJ, 1986
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985
- Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction.BMJ, 1983